Skip to content

Clinical trials

Completed Phase 3 Idiopathic Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Phase: Phase 3 Status: Completed Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20051
20062
20073
20082
20091
20111
20121
20131
20151
20162
20171
20202
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Genentech, Inc.4
Actelion2
Duke University2
United Therapeutics2
Asahi Kasei Therapeutics Corporation1
Assistance Publique - Hôpitaux de Paris1
Cellular Sciences, inc.1
Fernando J Martinez1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis24
Lung Diseases, Interstitial4
Pulmonary Fibrosis4
Fibrosis3
Bronchiectasis1
Cough1
Cystic Fibrosis1
Hypertension, Pulmonary1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.